In this manuscript, we have shown that CHID1 expression levels were significantly downregulated in AD patients and correlated positively with NRGN and CALB1 and negatively with IBA1 and CD31 in the brain of NDHC subjects. The gene discussed is PECAM1; the disease is Alzheimer disease.